June 24, 2024 8am - 4pm
June 24, 2024 8am - 4pm
September 15, 2023 8am-3pm
This year’s roundtable (in its 14th year) will focus on metrics + strategies for advancing bioethics, patient-centricity + health equity across the bio-pharmaceutical sector and amplifying + connecting participants’ work in these areas. Discussions may inform agenda-setting + metrics development for the Good Pharma Scorecard. Sessions will begin w/ opening remarks + transition to open discussion.
July 17, 2023
This year’s Trialscope event featured keynote speakers Jennifer Miller, PhD, founding president of Bioethics International and director of the Good Pharma Scorecard; and David Evans, president and CEO of the Clinical Data Interchange Standards Consortium (CDISC). Topics included DEI data sharing.
This was a gathering of industry leaders, regulatory experts, and technology enthusiasts focused on cutting-edge insights to shape the future of clinical trial disclosure.
October 19, 2022 — October 20, 2022
The National Health Council hosts its 2022 Science of Patient Engagement Symposium, From Research to Action: Health Equity for All. Over the past ears, the COVID-19 pandemic has upended the world and magnified health inequities among historically underrepresented racial/ethnic groups. The science of understanding the patient has never been more important. Health equity research, where diverse patients are at the core of scientific inquiry, is imperative to tackling inequities. BEI’s Founder, Jennifer E. Miller, PHD, will Keynote on Trust in Medical Research.
June 9, 2022 9am-4:15pm
This year’s bioethics roundtable, our 12th!, is hosted by Deloitte and will focus on equity and social responsibility in the bio-pharmaceutical sector and debut our new Good Pharma Scorecard (GPS) rankings on diversity and fair inclusion in research.
When: June 9, 2022 – 9am-4:15pm ET
Where: Deloitte’s NYC Offices
September 21, 2020 1:00PM-2:15PM EDT
ISPOR and the Innovation and Value Initiative (IVI) are collaborating—with help from an expert advisory committee—to define a series of dialogues that highlight key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic. The webinar series will explore multiple viewpoints and focus on potential pathways for solutions in international and U.S.-focused health technology assessment and value assessment (VA/HTA).
